These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 6466193)
1. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Morel DW; DiCorleto PE; Chisolm GM Arteriosclerosis; 1984; 4(4):357-64. PubMed ID: 6466193 [TBL] [Abstract][Full Text] [Related]
2. Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation. Fox PL; Chisolm GM; DiCorleto PE J Biol Chem; 1987 May; 262(13):6046-54. PubMed ID: 3571245 [TBL] [Abstract][Full Text] [Related]
3. Cell-mediated oxidation of LDL: comparison of different cell types of the atherosclerotic lesion. Müller K; Carpenter KL; Mitchinson MJ Free Radic Res; 1998 Sep; 29(3):207-20. PubMed ID: 9802552 [TBL] [Abstract][Full Text] [Related]
4. Correlation between oxidation of low density lipoproteins and prostacyclin synthesis in cultured smooth muscle cells. Ek B; Humble L Biochem Pharmacol; 1991 Mar; 41(5):695-9. PubMed ID: 1900157 [TBL] [Abstract][Full Text] [Related]
5. Interaction of native and cell-modified low density lipoprotein with collagen gel. Hoover GA; McCormick S; Kalant N Arteriosclerosis; 1988; 8(5):525-34. PubMed ID: 3190558 [TBL] [Abstract][Full Text] [Related]
6. Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Augé N; Pieraggi MT; Thiers JC; Nègre-Salvayre A; Salvayre R Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):1015-20. PubMed ID: 7639678 [TBL] [Abstract][Full Text] [Related]
7. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Parthasarathy S; Printz DJ; Boyd D; Joy L; Steinberg D Arteriosclerosis; 1986; 6(5):505-10. PubMed ID: 3767695 [TBL] [Abstract][Full Text] [Related]
8. Enhanced macrophage degradation of biologically modified low density lipoprotein. Henriksen T; Mahoney EM; Steinberg D Arteriosclerosis; 1983; 3(2):149-59. PubMed ID: 6838433 [TBL] [Abstract][Full Text] [Related]
9. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. Cathcart MK; Morel DW; Chisolm GM J Leukoc Biol; 1985 Aug; 38(2):341-50. PubMed ID: 3861749 [TBL] [Abstract][Full Text] [Related]
10. Role of endothelial cells and their products in the modification of low-density lipoproteins. van Hinsbergh VW; Scheffer M; Havekes L; Kempen HJ Biochim Biophys Acta; 1986 Aug; 878(1):49-64. PubMed ID: 3730414 [TBL] [Abstract][Full Text] [Related]
11. Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants. Guyton JR; Lenz ML; Mathews B; Hughes H; Karsan D; Selinger E; Smith CV Atherosclerosis; 1995 Dec; 118(2):237-49. PubMed ID: 8770318 [TBL] [Abstract][Full Text] [Related]
12. Oxidized low density lipoprotein stimulates collagen production in cultured arterial smooth muscle cells. Jimi S; Saku K; Uesugi N; Sakata N; Takebayashi S Atherosclerosis; 1995 Jul; 116(1):15-26. PubMed ID: 7488330 [TBL] [Abstract][Full Text] [Related]
13. Ceruloplasmin enhances smooth muscle cell- and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism. Mukhopadhyay CK; Ehrenwald E; Fox PL J Biol Chem; 1996 Jun; 271(25):14773-8. PubMed ID: 8663020 [TBL] [Abstract][Full Text] [Related]
14. Phenothiazines inhibit copper and endothelial cell-induced peroxidation of low density lipoprotein. A comparative study with probucol, butylated hydroxytoluene and vitamin E. Breugnot C; Mazière C; Salmon S; Auclair M; Santus R; Morlière P; Lenaers A; Mazière JC Biochem Pharmacol; 1990 Nov; 40(9):1975-80. PubMed ID: 2242028 [TBL] [Abstract][Full Text] [Related]
15. Oxidized LDL from subjects with different dietary habits modifies atherogenic processes in endothelial and smooth muscle cells. Lähteenmäki TA; Seppo L; Laakso J; Korpela R; Vanhanen H; Tikkanen MJ; Vapaatalo H Life Sci; 2000; 66(5):455-65. PubMed ID: 10670834 [TBL] [Abstract][Full Text] [Related]
16. Role of superoxide in endothelial-cell modification of low-density lipoproteins. Steinbrecher UP Biochim Biophys Acta; 1988 Mar; 959(1):20-30. PubMed ID: 2830901 [TBL] [Abstract][Full Text] [Related]
17. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Kapiotis S; Hermann M; Held I; Seelos C; Ehringer H; Gmeiner BM Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2868-74. PubMed ID: 9409268 [TBL] [Abstract][Full Text] [Related]
18. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Cominacini L; Garbin U; Pasini AF; Davoli A; Campagnola M; Contessi GB; Pastorino AM; Lo Cascio V Free Radic Biol Med; 1997; 22(1-2):117-27. PubMed ID: 8958136 [TBL] [Abstract][Full Text] [Related]
19. Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages. Hoff HF; O'Neil J; Chisolm GM; Cole TB; Quehenberger O; Esterbauer H; Jürgens G Arteriosclerosis; 1989; 9(4):538-49. PubMed ID: 2751482 [TBL] [Abstract][Full Text] [Related]
20. Uptake and degradation of low density lipoproteins (LDL) by confluent, contact-inhibited bovine and human endothelial cells exposed to physiological concentrations of LDL. Coetzee GA; Stein O; Stein Y Atherosclerosis; 1979 Aug; 33(4):425-31. PubMed ID: 228681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]